Oren Gilad - President, CEO, Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Oren Gilad - trading volume in the past year for Aprea Therapeutics, Inc.

Holdings reported by Oren Gilad for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 331K $2.42M $7.29 Mar 28, 2024 Direct
Common Stock 1.2K $8.75K $7.29 Mar 28, 2024 By daughter
Common Stock 600 $4.37K $7.29 Mar 28, 2024 By son
Stock Options (Right to Buy) 26.9K Mar 28, 2024 Direct Common Stock
Tranche A Warrant 1K Mar 13, 2024 Direct Common Stock
Tranche B Warrant 1K Mar 13, 2024 Direct Common Stock

Transactions reported by Oren Gilad for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.